National Institute on Drug Abuse (NIDA): Schizophrenia trials

The registry lists 18 Schizophrenia studies with National Institute on Drug Abuse (NIDA) as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 3Phase 4 2No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Brain Functions Underlying Visuospatial Attention Deficits in SchizophreniaCompletedNCT01399437
• Brain Circuits in Schizophrenia and SmokingCompletedNCT01369966
• Nicotinic Receptor Density in Smoking and Nonsmoking SchizophrenicsWithdrawnNCT01246128
• Effects of Antipsychotics on Eating and Food Craving in People With SchizophreniaCompletedNCT01222793
• Assessment of Cannabis Craving in Schizophrenia Using Virtual RealityCompletedNCT01212081
• fMRI Study of Nicotinic Effect on Neurophysiology of SchizophreniaCompletedNCT01046526
• Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug DependenceCompletedNCT01037075
• Neuroimaging Studies of Neurophysiological Phenotypes in SchizophreniaCompletedNCT01036568
• Dopamine Function and Reward Processing In SchizophreniaCompletedNCT01035996
• Effects of Nicotine on Areas of Impaired and Preserved Functioning in SchizophreniaCompletedNCT01034085
• Risk Perception in Drug-Dependent Adults With and Without SchizophreniaCompletedNCT01031563
• Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual RealityCompletedNCT01031433
• Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who SmokeCompletedNCT00307203Phase 4
• Effect of Bupropion on Smoking Behavior in Smokers With SchizophreniaCompletedNCT00218231Phase 2
• Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With SchizophreniaCompletedNCT00218218Phase 2
• Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2CompletedNCT00135772
• Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1CompletedNCT00124683Phase 2
• Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1TerminatedNCT00046813Phase 4